Simon T. Hodgson

969 total citations
30 papers, 567 citations indexed

About

Simon T. Hodgson is a scholar working on Organic Chemistry, Immunology and Molecular Biology. According to data from OpenAlex, Simon T. Hodgson has authored 30 papers receiving a total of 567 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Organic Chemistry, 11 papers in Immunology and 10 papers in Molecular Biology. Recurrent topics in Simon T. Hodgson's work include Mast cells and histamine (8 papers), Chemokine receptors and signaling (7 papers) and Asthma and respiratory diseases (6 papers). Simon T. Hodgson is often cited by papers focused on Mast cells and histamine (8 papers), Chemokine receptors and signaling (7 papers) and Asthma and respiratory diseases (6 papers). Simon T. Hodgson collaborates with scholars based in United Kingdom, United States and Switzerland. Simon T. Hodgson's co-authors include David M. Hollinshead, Steven V. Ley, T K Daneshmend, Aaron D. Norman, Christopher J. Hawkey, Derek J. Chadwick, David A. Hall, Robert J. Slack, Panayiotis A. Procopiou and Alison J. Ford and has published in prestigious journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry and Tetrahedron.

In The Last Decade

Simon T. Hodgson

30 papers receiving 537 citations

Peers

Simon T. Hodgson
Carl A. Baxter United Kingdom
Rita Nigam Canada
Jasbir Singh United States
Arthur G. Romero United States
Toufan Parman United States
David M. Ritchie United States
Simon T. Hodgson
Citations per year, relative to Simon T. Hodgson Simon T. Hodgson (= 1×) peers Huihui Zeng

Countries citing papers authored by Simon T. Hodgson

Since Specialization
Citations

This map shows the geographic impact of Simon T. Hodgson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon T. Hodgson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon T. Hodgson more than expected).

Fields of papers citing papers by Simon T. Hodgson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon T. Hodgson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon T. Hodgson. The network helps show where Simon T. Hodgson may publish in the future.

Co-authorship network of co-authors of Simon T. Hodgson

This figure shows the co-authorship network connecting the top 25 collaborators of Simon T. Hodgson. A scholar is included among the top collaborators of Simon T. Hodgson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon T. Hodgson. Simon T. Hodgson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Edwards, Hannah J., Declan Evans, Simon T. Hodgson, et al.. (2022). Sebetralstat (KVD900): A Potent and Selective Small Molecule Plasma Kallikrein Inhibitor Featuring a Novel P1 Group as a Potential Oral On-Demand Treatment for Hereditary Angioedema. Journal of Medicinal Chemistry. 65(20). 13629–13644. 13 indexed citations
2.
Procopiou, Panayiotis A., Alison J. Ford, Simon T. Hodgson, et al.. (2017). Design of Phthalazinone Amide Histamine H1 Receptor Antagonists for Use in Rhinitis. ACS Medicinal Chemistry Letters. 8(5). 577–581. 12 indexed citations
3.
Miah, Afjal H., et al.. (2017). Identification of pyrazolopyrimidine arylsulfonamides as CC-chemokine receptor 4 (CCR4) antagonists. Bioorganic & Medicinal Chemistry. 25(20). 5327–5340. 8 indexed citations
4.
Procopiou, Panayiotis A., Alison J. Ford, Ashley P. Hancock, et al.. (2017). Identification of selective 8-(piperidin-4-yloxy)quinoline sulfone and sulfonamide histamine H1 receptor antagonists for use in allergic rhinitis. Bioorganic & Medicinal Chemistry Letters. 27(21). 4914–4919. 2 indexed citations
5.
Procopiou, Panayiotis A., Ashley P. Hancock, Simon T. Hodgson, et al.. (2016). The discovery of quinoline based single-ligand human H1 and H3 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 26(24). 5855–5859. 6 indexed citations
6.
Shukla, Lena, Laura Ajram, Malcolm Begg, et al.. (2016). 2,8-Diazaspiro[4.5]decan-8-yl)pyrimidin-4-amine potent CCR4 antagonists capable of inducing receptor endocytosis. European Journal of Medicinal Chemistry. 115. 14–25. 6 indexed citations
7.
Heifetz, Alexander, Gebhard F. X. Schertler, Roland Seifert, et al.. (2015). GPCR structure, function, drug discovery and crystallography: report from Academia-Industry International Conference (UK Royal Society) Chicheley Hall, 1–2 September 2014. Naunyn-Schmiedeberg s Archives of Pharmacology. 388(8). 883–903. 28 indexed citations
8.
Ajram, Laura, Malcolm Begg, Robert J. Slack, et al.. (2014). Internalization of the chemokine receptor CCR4 can be evoked by orthosteric and allosteric receptor antagonists. European Journal of Pharmacology. 729. 75–85. 40 indexed citations
10.
Procopiou, Panayiotis A., et al.. (2012). Lead optimisation of the N1 substituent of a novel series of indazole arylsulfonamides as CCR4 antagonists and identification of a candidate for clinical investigation. Bioorganic & Medicinal Chemistry Letters. 22(8). 2730–2733. 16 indexed citations
11.
Young, Robert J., W. Alderton, Paul Beswick, et al.. (2011). Heteroalicyclic carboxamidines as inhibitors of inducible nitric oxide synthase; the identification of (2R)-2-pyrrolidinecarboxamidine as a potent and selective haem-co-ordinating inhibitor. Bioorganic & Medicinal Chemistry Letters. 21(10). 3037–3040. 2 indexed citations
12.
Hodgson, Simon T., et al.. (2004). Chemokines and drug discovery.. PubMed. 17(5). 335–8. 6 indexed citations
13.
Macdonald, Simon J. F., Michael D. Dowle, Lee A. Harrison, et al.. (2002). Discovery of Further Pyrrolidine trans-Lactams as Inhibitors of Human Neutrophil Elastase (HNE) with Potential as Development Candidates and the Crystal Structure of HNE Complexed with an Inhibitor (GW475151). Journal of Medicinal Chemistry. 45(18). 3878–3890. 48 indexed citations
14.
Evans, G. O., et al.. (1997). Structure–Activity Relationship for Two Lipoxygenase Inhibitors and Their Potential for Inducing Nephrotic Syndrome. Toxicology and Applied Pharmacology. 146(2). 299–308. 1 indexed citations
15.
Hawkey, Christopher J., et al.. (1990). Effect of reactive pharmacy intervention on quality of hospital prescribing.. BMJ. 300(6730). 986–990. 101 indexed citations
16.
Begley, Michael J., Paul V. Fish, Gerald Pattenden, & Simon T. Hodgson. (1990). Synthesis of marine toxins. A biomimetic approach to the novel spirobenzoquinonefuran stypoldione. Journal of the Chemical Society Perkin Transactions 1. 2263–2263. 14 indexed citations
17.
Hodgson, Simon T., David M. Hollinshead, & Steven V. Ley. (1985). Synthesis of the β-lactam antibiotic (+)- thienamycin via an intermediate π-allyltricarbonyliron lactone complex. Tetrahedron. 41(24). 5871–5878. 21 indexed citations
18.
Hodgson, Simon T., David M. Hollinshead, & Steven V. Ley. (1984). π-Allyltricarbonyliron lactone complexes in synthesis: application to the synthesis of the β-lactam antibiotic (+)-thienamycin. Journal of the Chemical Society Chemical Communications. 494–496. 16 indexed citations
19.
Chadwick, Derek J. & Simon T. Hodgson. (1983). The protecting–directing role of the trityl group in syntheses of pyrrole derivatives: efficient preparations of 1-H-pyrrole-3-carboxylic acid and 3-acyl-, 3-amino-, and 3-bromo-1-tritylpyrroles. Journal of the Chemical Society Perkin Transactions 1. 93–102. 22 indexed citations
20.
Annis, Gary D., et al.. (1983). Synthesis of β-lactams from π-allyltricarbonyliron (lactone) complexes. Journal of the Chemical Society Perkin Transactions 1. 2851–2856. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026